Cargando…

miR-26b-5p suppresses chemoresistance in breast cancer by targeting serglycin

Chemoresistance is a crucial barrier to limit the therapeutic outcome of breast cancer (BC), and the mechanism underlying chemoresistance development in BC is not fully understood. In this study, we aimed to investigate the potential involvement of miR-26b-5p/serglycin (SRGN) axis in BC drug resista...

Descripción completa

Detalles Bibliográficos
Autores principales:	Du, Qiwei, Yuan, Zuguo, Huang, Xiaoling, Huang, Yuqing, Zhang, Jie, Li, Rongguo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2021
Materias:	Original Studies
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8812413/ https://www.ncbi.nlm.nih.gov/pubmed/34924500 http://dx.doi.org/10.1097/CAD.0000000000001268

Ejemplares similares

Serglycin in human cancers
por: Li, Xin-Jian, et al.
Publicado: (2011)

Serglycin: At the Crossroad of Inflammation and Malignancy
por: Korpetinou, Angeliki, et al.
Publicado: (2014)

Cathepsin L promotes chemresistance to neuroblastoma by modulating serglycin
por: Du, Xiaohuan, et al.
Publicado: (2022)

Serglycin Is Implicated in the Promotion of Aggressive Phenotype of Breast Cancer Cells
por: Korpetinou, Angeliki, et al.
Publicado: (2013)

Serglycin as a potential biomarker for glioma: association of serglycin expression, extent of mast cell recruitment and glioblastoma progression
por: Roy, Ananya, et al.
Publicado: (2017)

miR-613 Suppresses Chemoresistance and Stemness in Triple-Negative Breast Cancer by Targeting FAM83A
por: Liu, Cuiping, et al.
Publicado: (2020)

miR-590-5p suppresses hepatocellular carcinoma chemoresistance by targeting YAP1 expression
por: Chen, Minjiang, et al.
Publicado: (2018)

Exosome-mediated breast cancer chemoresistance via miR-155 transfer
por: Santos, Juliana Carvalho, et al.
Publicado: (2018)

Tumor-suppressive miR-26a and miR-26b inhibit cell aggressiveness by regulating FUT4 in colorectal cancer
por: Li, Yang, et al.
Publicado: (2017)

Serglycin in Quiescent and Proliferating Primary Endothelial Cells
por: Reine, Trine M., et al.
Publicado: (2015)

Circulating MiR-125b as a Marker Predicting Chemoresistance in Breast Cancer
por: Wang, Hongjiang, et al.
Publicado: (2012)

Identification of miR-10b, miR-26a, miR-146a and miR-153 as potential triple-negative breast cancer biomarkers
por: Fkih M’hamed, Insaf, et al.
Publicado: (2015)

LncRNA Sox2OT-V7 promotes doxorubicin-induced autophagy and chemoresistance in osteosarcoma via tumor-suppressive miR-142/miR-22
por: Zhu, Kewei, et al.
Publicado: (2020)

Serglycin is part of the secretory repertoire of LPS-activated monocytes
por: Kolseth, Ingrid Benedicte M, et al.
Publicado: (2015)

Targeting Serglycin Prevents Metastasis in Murine Mammary Carcinoma
por: Roy, Ananya, et al.
Publicado: (2016)

Tumor-suppressing roles of miR-214 and miR-218 in breast cancer
por: LIU, BO, et al.
Publicado: (2016)

LncRNA SNHG7 Mediates the Chemoresistance and Stemness of Breast Cancer by Sponging miR-34a
por: Li, Zhi-hua, et al.
Publicado: (2020)

Clinical impact of circulating miR-26a, miR-191, and miR-208b in plasma of patients with acute myocardial infarction
por: Li, Chencheng, et al.
Publicado: (2015)

MiR-200b regulates autophagy associated with chemoresistance in human lung adenocarcinoma
por: Pan, Banzhou, et al.
Publicado: (2015)

Bmi-1-induced miR-27a and miR-155 promote tumor metastasis and chemoresistance by targeting RKIP in gastric cancer
por: Li, Yaqing, et al.
Publicado: (2020)

Circulating miR-92b and miR-375 for monitoring the chemoresistance and prognosis of small cell lung cancer
por: Li, Ming, et al.
Publicado: (2020)

MiR-181b suppresses proliferation of and reduces chemoresistance to temozolomide in U87 glioma stem cells()
por: Li, Ping, et al.
Publicado: (2010)

Circular RNA CDR1as Alleviates Cisplatin-Based Chemoresistance by Suppressing MiR-1299 in Ovarian Cancer
por: Wu, Han, et al.
Publicado: (2022)

Tumor suppression by miR-26 overrides potential oncogenic activity in intestinal tumorigenesis
por: Zeitels, Lauren R., et al.
Publicado: (2014)

Serglycin proteoglycans limit enteropathy in Trichinella spiralis-infected mice
por: Roy, Ananya, et al.
Publicado: (2016)

Molecular Interactions Stabilizing the Promatrix Metalloprotease-9·Serglycin Heteromer
por: Dawadi, Rangita, et al.
Publicado: (2020)

The relationship between plasma serglycin levels and the diagnosis of diabetic retinopathy
por: Wang, Layi, et al.
Publicado: (2020)

A miR-20a/MAPK1/c-Myc regulatory feedback loop regulates breast carcinogenesis and chemoresistance
por: Si, Wengong, et al.
Publicado: (2018)

Trastuzumab Produces Therapeutic Actions by Upregulating miR-26a and miR-30b in Breast Cancer Cells
por: Ichikawa, Takehiro, et al.
Publicado: (2012)

The Roles of miR-26, miR-29, and miR-203 in the Silencing of the Epigenetic Machinery during Melanocyte Transformation
por: Gasque Schoof, Cláudia Regina, et al.
Publicado: (2015)

Expression and predictive value of miR-489 and miR-21 in melanoma metastasis
por: Mo, Hao, et al.
Publicado: (2019)

The Antitumor Effect of Metformin Is Mediated by miR-26a in Breast Cancer
por: Cabello, Paula, et al.
Publicado: (2016)

Circulating miR-20a and miR-26a as Biomarkers in Prostate Cancer
por: Torbati, Peyman Mohammadi, et al.
Publicado: (2019)

Echinacoside Suppresses the Progression of Breast Cancer by Downregulating the Expression of miR-4306 and miR-4508
por: Bian, Peng, et al.
Publicado: (2021)

Expression and significance of miR-654-5p and miR-376b-3p in patients with colon cancer
por: Li, Ping, et al.
Publicado: (2020)

MiR-7-5p suppresses invasion via downregulation of the autophagy-related gene ATG7 and increases chemoresistance to cisplatin in BCa
por: Wang, Chong, et al.
Publicado: (2022)

MiR-26a/miR-26b represses tongue squamous cell carcinoma progression by targeting PAK1
por: Wei, Zhenxing, et al.
Publicado: (2020)

High miR-26a and low CDC2 levels associate with decreased EZH2 expression and with favorable outcome on tamoxifen in metastatic breast cancer
por: Jansen, M. P. H. M., et al.
Publicado: (2011)

miR-26a suppresses osteosarcoma migration and invasion by directly targeting HMGA1
por: Liu, Jianyong, et al.
Publicado: (2018)

miR-26 suppresses adipocyte progenitor differentiation and fat production by targeting Fbxl19
por: Acharya, Asha, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_nq61fnqvnkbgfrjoa1f20qc882